Case Studies
View all case studies

Patient journey analysis for a new oncology drug

Bundled payment can serve as a disincentive to provide high-cost drugs, so the client was interested
in pursuing reimbursement policy options that would ensure appropriate reimbursement to these
facilities, thus ensuring patient access to the drug during the treatment regimen.

Download the results and approach below.

Bundled payment can serve as a disincentive to provide high-cost drugs, so the client was interested
in pursuing reimbursement policy options that would ensure appropriate reimbursement to these
facilities, thus ensuring patient access to the drug during the treatment regimen.

Download the results and approach below.

Download

Contact our experts

Kevin Kirby

Kevin Kirby

Managing Director
Washington, DC
Clare Mamerow

Clare Mamerow

Principal
Washington, DC
Yaena Min

Yaena Min

Principal
Washington, DC
Mark Desmarais

Mark Desmarais

Principal
Washington, DC
Linh Tran

Linh Tran

Consultant
Washington, DC